According to the latest research by SNS Insider, the Pharmaceutical Gelatin Market Share was valued at USD 1.69 billion in 2023 and is poised to grow to USD 2.79 billion by 2032, registering a compound annual growth rate (CAGR) of 5.77% during the forecast period of 2024–2032. This substantial growth is attributed to the rising application of gelatin in soft and hard capsule manufacturing, growing investments in biopharmaceuticals, and increasing demand for controlled drug delivery systems.
Pharmaceutical gelatin, derived from collagen, plays a vital role in drug formulation due to its unique properties such as biocompatibility, thermo-reversibility, and excellent film-forming abilities. It is extensively used in the production of capsules, tablets, plasma expanders, and wound dressings. With the pharmaceutical industry increasingly shifting towards patient-centric formulations and personalized medicine, the demand for high-quality gelatin is witnessing a notable upsurge.
Key Market Drivers
- Rising Demand for Capsules: The consumption of gelatin-based capsules—both hard and soft—is increasing owing to their ease of ingestion and ability to effectively encapsulate drugs with poor solubility. This trend is particularly evident in geriatric and pediatric populations.
- Growth in Biopharmaceuticals: The expanding biopharmaceutical sector is utilizing gelatin for developing specialized drug delivery systems, particularly for biologics that require enhanced stability and targeted delivery.
- Advancements in Drug Delivery Technologies: Pharmaceutical companies are investing in innovative gelatin-based delivery systems such as microspheres and nanoparticles, further driving market growth.
- Regulatory Support: Global regulatory bodies are supporting the use of gelatin in pharmaceuticals due to its safe consumption profile, encouraging manufacturers to adopt it in various formulations.
Market Segmentation Highlights
- By Type: Type A gelatin (acid-processed) holds a dominant market share due to its faster manufacturing process and application versatility. However, Type B gelatin (alkaline-processed) is gaining traction for specific applications requiring higher bloom strength.
- By Source: Pig skin remains the primary source, although bovine-derived gelatin is also widely used. The demand for fish gelatin is increasing among consumers seeking halal, kosher, or non-mammalian options.
- By Application: Capsule production is the largest application segment, accounting for over 40% of the market share. Other significant applications include wound care, plasma expanders, and vaccine stabilizers.
Regional Insights
- North America: The region leads the global pharmaceutical gelatin market due to the presence of leading pharmaceutical companies, strong regulatory infrastructure, and high R&D investments.
- Europe: A well-established healthcare system, combined with rising consumption of dietary and pharmaceutical supplements, drives steady demand.
- Asia-Pacific: Emerging economies such as China and India are witnessing rapid growth, backed by expanding pharmaceutical manufacturing capabilities and increased healthcare spending.
Challenges and Opportunities
While the market exhibits strong growth potential, challenges such as fluctuations in raw material supply, religious dietary restrictions, and availability of vegan alternatives pose constraints. However, ongoing R&D focused on developing plant-based gelatin analogs and improved sourcing methods is expected to overcome these barriers.
Moreover, collaborations between pharmaceutical manufacturers and gelatin suppliers for customized product development will open new avenues for market expansion.
Competitive Landscape
Major players in the pharmaceutical gelatin market include Gelita AG, Rousselot, PB Leiner, Nitta Gelatin, Sterling Biotech, Tessenderlo Group, and Trobas Gelatine. These companies are focusing on strategic mergers, product innovations, and sustainable sourcing to strengthen their market presence.
Future Outlook
With advancements in healthcare, increasing chronic disease prevalence, and growing awareness about health supplements, the pharmaceutical gelatin market is set for a significant transformation over the next decade. Sustainability initiatives and innovations in gelatin alternatives may also diversify the market offerings, appealing to a broader consumer base.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
📧 info@snsinsider.com
📞 +1-415-230-0044 (US) | +91-7798602273 (IND)
Other Trending Reports
Compression Therapy Market Share